Mexico
· Delayed Price · Currency is MXN Teladoc Health Statistics
Total Valuation
Teladoc Health has a market cap or net worth of MXN 36.64 billion. The enterprise value is 43.73 billion.
| Market Cap | 36.64B |
| Enterprise Value | 43.73B |
Important Dates
The next estimated earnings date is Thursday, February 20, 2025.
| Earnings Date | Feb 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +3.23% |
| Shares Change (QoQ) | +0.74% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 161.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 26.83, with an EV/FCF ratio of 6.73.
| EV / Earnings | -2.27 |
| EV / Sales | 0.82 |
| EV / EBITDA | 26.83 |
| EV / EBIT | n/a |
| EV / FCF | 6.73 |
Financial Position
The company has a current ratio of 1.73, with a Debt / Equity ratio of 1.05.
| Current Ratio | 1.73 |
| Quick Ratio | 1.58 |
| Debt / Equity | 1.05 |
| Debt / EBITDA | 20.05 |
| Debt / FCF | 4.79 |
| Interest Coverage | -8.74 |
Financial Efficiency
Return on equity (ROE) is -51.65% and return on invested capital (ROIC) is -3.52%.
| Return on Equity (ROE) | -51.65% |
| Return on Assets (ROA) | -3.13% |
| Return on Invested Capital (ROIC) | -3.52% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 9.74M |
| Profits Per Employee | -3.69M |
| Employee Count | 5,600 |
| Asset Turnover | 0.66 |
| Inventory Turnover | 20.73 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -37.43% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -37.43% |
| 50-Day Moving Average | 206.23 |
| 200-Day Moving Average | 185.30 |
| Relative Strength Index (RSI) | 59.49 |
| Average Volume (20 Days) | 1,412 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.45 |
Income Statement
In the last 12 months, Teladoc Health had revenue of MXN 50.71 billion and -19.22 billion in losses. Loss per share was -113.85.
| Revenue | 50.71B |
| Gross Profit | 35.91B |
| Operating Income | -3.85B |
| Pretax Income | -19.01B |
| Net Income | -19.22B |
| EBITDA | 1.30B |
| EBIT | -3.85B |
| Loss Per Share | -113.85 |
Balance Sheet
The company has 24.36 billion in cash and 31.11 billion in debt, giving a net cash position of -6.76 billion.
| Cash & Cash Equivalents | 24.36B |
| Total Debt | 31.11B |
| Net Cash | -6.76B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 29.52B |
| Book Value Per Share | 171.71 |
| Working Capital | 13.26B |
Cash Flow
In the last 12 months, operating cash flow was 6.62 billion and capital expenditures -118.71 million, giving a free cash flow of 6.50 billion.
| Operating Cash Flow | 6.62B |
| Capital Expenditures | -118.71M |
| Free Cash Flow | 6.50B |
| FCF Per Share | n/a |
Margins
Gross margin is 70.82%, with operating and profit margins of -7.59% and -37.91%.
| Gross Margin | 70.82% |
| Operating Margin | -7.59% |
| Pretax Margin | -37.49% |
| Profit Margin | -37.91% |
| EBITDA Margin | 2.56% |
| EBIT Margin | -7.59% |
| FCF Margin | 12.81% |
Dividends & Yields
Teladoc Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.23% |
| Shareholder Yield | -3.23% |
| Earnings Yield | -52.47% |
| FCF Yield | 17.74% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Teladoc Health has an Altman Z-Score of -4.93. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.93 |
| Piotroski F-Score | n/a |